Evaluation of mid-term results of bipolar transurethral resection in the treatment of benign prostatic hyperplasia
DOI:
https://doi.org/10.25726/NM.2019.77.26.001Keywords:
benign prostatic hyperplasia, bipolar transurethral resection of the prostate, prostate, blood loss, complication, treatment costs, hospitalizationAbstract
The clinical results of surgical treatment of benign prostatic hyperplasia (BPH) up to 100 cm3 by bipolar transurethral resection of the prostate (BTUR - 74 patients) in comparison with open transvesical prostatectomy (OPE - 96 patients), previously used for such clinical cases in the urological clinic "Railway hospital" in Volgograd are presented. With statistically equal operating time of both surgical methods, there was a significant decrease in intraoperative blood loss, the terms of postoperative catheterization and hospital stay, the minimum frequency of hemorrhagic and infectious-inflammatory complications.
Observation of the urological status of patients during the first postoperative year showed the same clinical efficacy of the compared surgical methods. A significant reduction in the volume of blood loss during the operation, can be considered a great achievement, since the improvement of visibility in the area of surgical intervention allows to optimize the hemostasis, to prevent massive bleeding during and after surgery, to reduce the duration of postoperative bladder catheterization, which, in turn, reduces the incidence of infectious-inflammatory complications. Faster recovery of patients after endoscopic surgery of medical,social and economic importance, as the minimum number of postoperative complications and reduction of hospitalization can significantly reduce the cost of treatment and quickly normalize the quality of life of patients.
The results demonstrate the prospects of the introduction of bipolar methods of endoscopic surgery for the treatment of BPH in the surgical practice of urological hospitals in order to improve the safety of surgical treatment and save costs for hospitalization.
References
2. Gorilovsky L.M., Zingerenko M.B. (2011). Posleoperacionnye oslozhnenija transuretral'noj rezekcii prostaty [Postoperative complications of transurethral resection of the prostate]. Klinicheskaja gerontologija [Clinical Gerontology], 9, 3-7. (In Russ.)
3. Kalininskaya A.A., Mashin A.G., Sevryukov F.A. (2013). Faktory riska razvitija giperplazii predstatel'noj zhelezy [Risk factors for developing prostatic hyperplasia]. Social'nye aspekty zdorov'ja naselenija [Social aspects of public health], 29 (1), 1-9. (In Russ.)
4. Kalininskaya A.A., Sevryukov F.A. (2012). Sovremennye vozmozhnosti transuretral'noj jelektrorezekcii v fiziologicheskom rastvore v lechenii zabolevanij nizhnih mochevyh putej i prostaty [Modern possibilities of transurethral electroresection in physiological saline in the treatment of diseases of the lower urinary tract and prostate]. Mezhdunarodnyj zhurnal jeksperimental'nogo obrazovanija [International Journal of Experimental Education], 6, 41-43. (In Russ.)
5. Kamalov A.A., Gushchin B.L., Dorofeev S.D. [and etc.]. (2004). Sovremennye aspekty operativnogo lechenija dobrokachestvennoj giperplazii predstatel'noj zhelezy [Modern aspects of surgical treatment of benign prostatic hyperplasia]. Urologija [Urology], 1, 30-34. (In Russ.)
6. Kamalov A.A., Sevryukov F.A. (2012). Izuchenie jeffektivnosti bipoljarnoj transuretral'noj rezekcii adenomy prostaty srednih i malyh razmerov [Study of the effectiveness of bipolar transurethral resection of adenomas of the prostate of medium and small sizes]. Sovremennye tehnologii v medicine [Modern technologies in medicine], 4, 68-72. (In Russ.)
7. Lopatkin N.A. (2011). Transuretral'nye operacii na prostate. Oslozhnenija transuretral'noj rezekcii prostaty [Transurethral surgery on the prostate. Complications of transurethral resection of the prostate]. Urologija. Nacional'noe rukovodstvo [Urology. National leadership]. Moscow, GEOTAR-Media, 190–195. (In Russ.)
8. Markov A.V., Lukyanov I.V., Laurent O.B. (2007). Kompleksnaja terapija irritativnyh rasstrojstv mocheispuskanija posle transuretral'noj rezekcii prostaty i adenomjektomii [Combination therapy of irritative urination disorders after transurethral resection of the prostate and adenomectomy]. Urologija [Urology], 4, 41–44. (In Russ.)
9. Martov A.G., Merinov D.S., Kornienko S.I. [and etc.]. (2006). Posleoperacionnye urologicheskie oslozhnenija transuretral'nyh jelektrohirurgicheskih vmeshatel'stv na predstatel'noj zheleze po povodu adenomy [Postoperative urological complications of transurethral electrosurgical interventions on the prostate gland due to adenoma]. Urologija [Urology], 2, 25-31. (In Russ.)
10. Sevryukov F.A., Kamaev I.A., Mushroom M.N., Perevezentsev E.A. (2011). Osnovnye aspekty obespechenija vysokokvalificirovannoj urologicheskoj medicinskoj pomoshh'ju bol'nyh s dobrokachestvennoj giperplaziej predstatel'noj zhelezy [The main aspects of providing highly qualified urological medical care to patients with benign prostatic hyperplasia]. Rossijskij mediko-biologicheskij vestnik imeni akademika I.P. Pavlova [I.P. Pavlov Russian Medical Biological Herald], 19 (1), 109-113. (In Russ.)
11. Sevryukov F.A., Kamaev I.A., Malinina O.Yu., Mushroom M.N., Perevezentsev E.A. (2011). Social'nyj status pacientov, stradajushhih dobrokachestvennoj giperplaziej predstatel'noj zhelezy [The social status of patients suffering from benign prostatic hyperplasia]. Obshhestvennoe zdorov'e i zdravoohranenie [Public health and healthcare], 1, 53-56. (In Russ.)
12. Sevryukov F.A., Malinina O.Yu. (2012). Novye organizacionnye tehnologii okazanija medicinskoj pomoshhi bol'nym s dobrokachestvennoj giperplaziej predstatel'noj zhelezy [New organizational technologies for providing medical care to patients with benign prostatic hyperplasia]. Social'nye aspekty zdorov'ja naselenija [Social aspects of public health], 23 (1), 5. (In Russ.)
13. Sevryukov F.A. (2012). Transuretral'naja rezekcija v fiziologicheskom rastvore [Transurethral resection in saline]. Urologija [Urology], 2, 67-70. (In Russ.)
14. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. (2015). Sravnitel'naja ocenka bipoljarnoj transuretral'noj vaporezekcii (TUVRB) i bipoljarnoj rezekcii (TURIS) v lechenii dobrokachestvennoj giperplazii prostaty [Comparative evaluation of bipolar transurethral vapor resection (TUVRB) and bipolar resection (TURIS) in the treatment of benign prostatic hyperplasia]. Medicinskij vestnik Bashkortostana [Medical Bulletin of Bashkortostan], 10 (3), 16-19. (In Russ.)
15. Semenychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. (2017). Sravnitel'naja ocenka jeffektivnosti razlichnyh jenergeticheskih blokov v bipoljarnoj hirurgii prostaty [Comparative evaluation of the effectiveness of various energy blocks in bipolar prostate surgery]. Tihookeanskij medicinskij zhurnal [Pacific Medical Journal], 1 (67), 88-90. (In Russ.)
16. Sitdykov E.N., Zubkov A.Yu., Zubkov E.A. (2004). Vybor metoda lechenija bol'nyh s adenomoj predstatel'noj zhelezy [The choice of treatment for patients with prostate adenoma]. Kazanskij med. Zhurnal [Kazan Med. Magazine], 85(5), 356-359. (In Russ.)
17. Sitdykov E.N. (2004). Obstruktivnye oslozhnenija operativnogo lechenija DGPZh [Obstructive complications of surgical treatment of BPH]. Kazanskij med. Zhurnal [Kazan Med. Magazine], 5, 356–359. (In Russ.)
18. Sorokin D.A., Sevryukov F.A., Semenychev D.V., Karpukhin I.V., Puchkin A.B., Kochkin A.D., Knutov A.V. (2015). Rezul'taty primenenija gialuronovoj kisloty posle transuretral'nyh jendoskopicheskih operacij po povodu dobrokachestvennoj giperplazii prostaty [The results of the use of hyaluronic acid after transurethral endoscopic surgery for benign prostatic hyperplasia]. Medicinskij vestnik Bashkortostana [Medical Bulletin of Bashkortostan], 10 (3), 19-24. (In Russ.)
19. Tkachuk V.N. (2004). Sovremennye predstavlenija ob jetiologii i patogeneze dobrokachestvennoj giperplazii predstatel'noj zhelezy [Modern ideas about the etiology and pathogenesis of benign prostatic hyperplasia]. Nefrologija [Nephrology], 8(2), 90-93. (In Russ.)
20. Bruschini H., Simonetti R., Antunes A. A., Srougi M. (2011). Urinary incontinence following surgery for BPH: the role of aging on the incidence of bladder dysfunction. Int. Brazilian J. Urol., 37(3), 380–387.
21. Chen S., Zhu L., Cai J., et al. (2014). Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol., 66 (2), 284–291.
22. Liu C., Zheng S., Li H., Xu K. (2010). Transurethral enucleation and resection of prostate in patients with benign prostatic hyperplasia by plasma kinetics. J Urol., 184 (6), 2440-2445.
23. Parsons J.K., Kashefi C. (2008). Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol., 53, 1228-1235.
24. Patel N.D., Parsons J.K. (2014). Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol., 30 (2), 170-176.
25. Kamyshov S.V., Pulatov D.A., Nishanov D.A., Yuldasheva N.Sh., Yusupova N.B. (2017). Znachimost' ocenki molekuljarno-biologicheskih onkomarkerov v soprovoditel'noj immunoterapii pri rake shejki matki [Significance of evaluation of molecular biological tumor markers in accompanying immunotherapy in cervical cancer]. Onkologija i radiologija Kazahstana [Oncology and radiology of Kazakhstan], 2, 45-48. (In Russ.)
26. Salalykina E.V., Jablonka N.V. (2018). Aspekty organizacii raboty srednego medicinskogo personala otdelenija medicinskogo centra [Aspects of organization of work of paramedical personnel Department of the medical center]. International Journal of Medicine and Psychology, 1(4), 19-23. (In Russ.)
27. Kamyshov S.V., Nishanov D.A., Pulatov D.A., Yuldasheva N.S. (2017). Izuchenie markerov apoptoza, proliferacii i angiogeneza u bol'nyh rakom jaichnika, poluchivshih soprovoditel'nuju immunoterapiju [Study of markers of apoptosis, proliferation and angiogenesis in patients with ovarian cancer who received accompanying immunotherapy]. Zlokachestvennye opuholi [Malignant tumors], 1, 84–91. (In Russ.)
28. Ilchenko G. V., Ishchenko O. Yu., Lynova E.N., Prischep L.V. (2018). Ocenka organizacionnoj lojal'nosti v medicinskih uchrezhdenijah [Assessment of organizational loyalty in medical institutions]. International Journal of Medicine and Psychology, 1(4), 24-35. (In Russ.)